L286-1252 Screening compound: 4-(3-{4-methyl-3-[(4-phenylpiperazin-1-yl)sulfonyl]phenyl}-1,2,4-oxadiazole-5-carbonyl)morpholine

L286-1252 Screening compound: 4-(3-{4-methyl-3-[(4-phenylpiperazin-1-yl)sulfonyl]phenyl}-1,2,4-oxadiazole-5-carbonyl)morpholine
L286-1252 Screening compound: 4-(3-{4-methyl-3-[(4-phenylpiperazin-1-yl)sulfonyl]phenyl}-1,2,4-oxadiazole-5-carbonyl)morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound L286-1252
4-(3-{4-methyl-3-[(4-phenylpiperazin-1-yl)sulfonyl]phenyl}-1,2,4-oxadiazole-5-carbonyl)morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L286-1252

Molecular Formula

C24H27N5O5S (C24 H27 N5 O5 S)

Compound Name

4-(3-{4-methyl-3-[(4-phenylpiperazin-1-yl)sulfonyl]phenyl}-1,2,4-oxadiazole-5-carbonyl)morpholine

IUPAC name

4-(3-{4-methyl-3-[(4-phenylpiperazin-1-yl)sulfonyl]phenyl}-124-oxadiazole-5-carbonyl)morpholine

SMILES

Cc(ccc(-c1noc(C(N2CCOCC2)=O)n1)c1)c1S(N(CC1)CCN1c1ccccc1)(=O)=O

InChI

InChI=1S/C24H27N5O5S/c1-18-7-8-19(22-25-23(34-26-22)24(30)28-13-15-33-16-14-28)17-21(18)35(31,32)29-11-9-27(10-12-29)20-5-3-2-4-6-20/h2-8,17H,9-16H2,1H3

InChI Key

ZITGAVYCQZJJAR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27240595

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

497.58

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.024

Distribution Coefficient, logD

3.024

Water Solubility, LogSw

-3.28

Polar Surface Area

91.444

Acid Dissociation Constant (pKa)

26.27

Base Dissociation Constant (pKb)

2.22

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

L286-1252 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with L286-1252 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L286-1252?
Check Price and Availability of L286-1252, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L286-1252 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L286-1252
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L286-1252
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L286-1252 available by request